Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on peginterferon alfa-2a in HBeAg-negative chronic hepatitis B patients treated with nucleos(t)ide analogues
NL-OMON45209Phase 4Active, not recruiting
- Sponsor
- Stichting Leveronderzoek
- Start
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) (2 arms), sponsored by Stichting Leveronderzoek. Primary endpoint: HBsAg decline. Started Apr 2012; status: active, not recruiting.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NL-OMON45209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45209.